The health watchdog's latest guidance is a timely reminder of the importance of ongoing care for women living with Post-Menopausal Osteoporosis (PMOS). This debilitating condition affects millions, causing weakened bones that can lead to devastating fractures – even from minor falls. But with annual NHS checks, healthcare professionals hope to prevent these complications and improve patient outcomes.
PMOS is a common condition in post-menopausal women, caused by a drop in oestrogen levels that weakens bones. This makes them more susceptible to fractures, which can be particularly severe for older adults. The proposed annual checks are designed to monitor the effectiveness of treatment plans, ensure medication adherence, and address any new symptoms or concerns.
The management of PMOS varies across different NHS trusts and GP practices, but this new guidance aims to standardise care nationwide. By doing so, it's hoped that patient outcomes will improve, and the incidence of debilitating fractures will decrease. These fractures place a significant burden on the NHS, both in terms of emergency care and long-term rehabilitation.
According to the Royal Osteoporosis Society, osteoporosis affects around three million people in the UK, with post-menopausal women being a particularly vulnerable group. Data suggests that one in two women and one in five men over 50 will experience an osteoporosis-related fracture. Early diagnosis and consistent management are crucial in mitigating the progression of the disease and preventing severe complications.
While this guidance is not mandatory, its adoption by NHS England and local commissioning groups could lead to a more structured approach to PMOS care. This would involve GPs proactively scheduling annual reviews for patients with PMOS – potentially through a national screening or recall system. Patients should continue following their current treatment plans and consult their GP if they have any concerns.